A ligand-mediated dimerization mode for vancomycin.

BACKGROUND Vancomycin and related glycopeptide antibiotics exert their antimicrobial effect by binding to carboxy-terminal peptide targets in the bacterial cell wall and preventing the biosynthesis of peptidoglycan. Bacteria can resist the action of these agents by replacing the peptide targets with depsipeptides. Rational efforts to design new agents effective against resistant bacteria require a thorough understanding of the structural determinants of peptide recognition by vancomycin. RESULTS The crystal structure of vancomycin in complex with N-acetyl-D-alanine has been determined at atomic resolution. Two different oligomeric interactions are seen in the structure: back-to-back dimers, as previously described for the vancomycin-acetate complex, and novel face-to-face dimers, mediated largely by the bound ligands. Models of longer, naturally occurring peptide ligands may be built by extension of N-acetyl-D-alanine. These larger ligands can form an extensive array of polar and nonpolar interactions with two vancomycin monomers in the face-to-face configuration. CONCLUSIONS A new dimeric form of vancomycin has been found in which two monomers are related in a face-to-face configuration, and bound ligands comprise a large portion of the dimer interface. The relative importance of face-to-face and back-to-back dimers to the antimicrobial activity of vancomycin remains to be established, but face-to-face interactions appear to explain how increased antimicrobial activity may arise in covalent vancomycin dimers.

[1]  Swartz Mn.  Hospital-acquired infections: diseases with increasingly limited therapies. , 1994 .

[2]  Dudley H. Williams,et al.  Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics , 1995, Antimicrobial agents and chemotherapy.

[3]  Bart De Moor,et al.  Implementation and Applications , 1996 .

[4]  L. Scuderi.  A 2000-Year Tree Ring Record of Annual Temperatures in the Sierra Nevada Mountains , 1993, Science.

[5]  G. Rivas,et al.  Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides. , 1996, The Journal of antibiotics.

[6]  Dudley H. Williams,et al.  Measurement of the different affinities of the two halves of glycopeptide dimers for acetate , 1997 .

[7]  Jieping Zhu,et al.  Novel vancomycin dimers with activity against vancomycin-resistant enterococci , 1997 .

[8]  G. Sheldrick,et al.  Structure of ureido‐balhimycin , 1995 .

[9]  Joel P. Mackay,et al.  Dissection of the contributions toward dimerization of glycopeptide antibiotics , 1994 .

[10]  J. Mackay,et al.  The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics. , 1994, Structure.

[11]  G. Batta,et al.  An NMR study of eremomycin and its derivatives. Full 1H and 13C assignment, motional behavior, dimerization and complexation with Ac-D-Ala-D-Ala. , 1991, The Journal of antibiotics.

[12]  Dudley H. Williams,et al.  Aspects of molecular recognition: solvent exclusion and dimerization of the antibiotic ristocetin when bound to a model bacterial cell-wall precursor , 1989 .

[13]  D. Langs,et al.  Statistical expectation value of the Debye-Waller factor and E(hkl) values for macromolecular crystals. , 1996, Acta crystallographica. Section D, Biological crystallography.

[14]  Steven M. Gallo,et al.  SnB: crystal structure determination via shake-and-bake , 1994 .

[15]  H. Hauptman,et al.  On the application of the minimal principle to solve unknown structures. , 1993, Science.

[16]  R Miller,et al.  Structure solution by minimal-function phase refinement and Fourier filtering. II. Implementation and applications. , 1994, Acta crystallographica. Section A, Foundations of crystallography.

[17]  Paul H. Axelsen,et al.  Simultaneous Recognition of a Carboxylate-Containing Ligand and an Intramolecular Surrogate Ligand in the Crystal Structure of an Asymmetric Vancomycin Dimer , 1997 .

[18]  S. Macura,et al.  Simulated dipeptide recognition by vancomycin , 1997, Journal of molecular recognition : JMR.

[19]  Dudley H. Williams,et al.  Glycopeptide antibiotic activity and the possible role of dimerization : A model for biological signaling , 1994 .

[20]  Dudley H. Williams,et al.  The role of the sugar and chlorine substituents in the dimerization of vancomycin antibiotics , 1993 .

[21]  M. Swartz,et al.  Hospital-acquired infections: diseases with increasingly limited therapies. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Dudley H. Williams,et al.  ASYMMETRY IN THE STRUCTURE OF GLYCOPEPTIDE ANTIBIOTIC DIMERS : NMR STUDIESOF THE RISTOCETIN A COMPLEX WITH A BACTERIAL CELL WALL ANALOGUE , 1995 .

[23]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .

[24]  J. Griffin,et al.  Novel Vancomycin Dimers with Activity against Vancomycin-Resistant Enterococci , 1996 .

[25]  Dudley H. Williams,et al.  Binding of a vancomycin group antibiotic to a cell wall analogue from vancomycin-resistant bacteria , 1996 .

[26]  G. Sheldrick,et al.  SHELXL: high-resolution refinement. , 1997, Methods in enzymology.

[27]  G. Sheldrick,et al.  Crystal structure of vancomycin. , 1996, Structure.

[28]  Dudley H. Williams,et al.  Cooperativity in ligand binding expressed at a model cell membrane by the vancomycin group antibiotics , 1996 .